| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.25 | 5e-05 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |